Technical Due Diligence

Technical Due Diligence
Product Description

For companies that are:

  • Buying a Product outright
  • In-licensing a Product
  • Acquiring or Licensing Technology
  • Acquiring a Division
  • Acquiring a whole Company


To cover the wide range of disciplines involved in Technical Due Diligence, Explicat® Pharma provides clients a portal to managed teams of experts in the appropriate fields for both pipeline and marketed products as well as licensing and merger and acquisition activities.

Read more Show less

Explicat Pharma GmbH

  • DE
  • 2015
    On CPHI since
  • 1 - 24
    Employees
Company types
Contract Service
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Experienced Technicians; Quality Service
  • Supplied from
    Germany
More specifications Fewer specifications
Sales Markets
Show more Show less

Explicat Pharma GmbH

  • DE
  • 2015
    On CPHI since
  • 1 - 24
    Employees
Company types
Contract Service
View company profile

More Products from Explicat Pharma GmbH (2)

  • Consulting and advisory services for gmp, risk analysis, new product development strategy

    Product Consulting and advisory services for gmp, risk analysis, new product development strategy

    Explicat Pharma GmbH offers consulting and advisory services for gmp, risk analysis, new product development strategypharmaceutical services. Contact us for more information.
  • Technical Project Management

    Product Technical Project Management

    “You have an early development candidate – we take the responsibility to develop it and get it on the market”

    We use an integrated fast-track drug development approach to achieve this goal.

    • Sourcing • Chemical Development / Biotechnological Development • Pharmaceutical Develo...

Explicat Pharma GmbH resources (1)

  • A CASE STUDY TO OPTIMIZE FREEZE DRYINGCONDITIONS OF CYCLODEXTRIN-BASED FORMULATIONS

    Whitepaper A CASE STUDY TO OPTIMIZE FREEZE DRYINGCONDITIONS OF CYCLODEXTRIN-BASED FORMULATIONS

    SBECD (Sulfobutylether - β - Cyclodextrin) is a new andpromising excipient for freeze dried formulations. Thepresent study illustrates an approach to optimize freezedrying conditions for formulations containing SBECD.First, a placebo was used to evaluate a general freezedrying recipe. Further, the information gained wascompared with drug product runs.
    (PDF) A CASE STUDY TO OPTIMIZE FREEZE DRYING CONDITIONS OF CYCLODEXTRIN-BASED FORMULATIONS. Available from: https://www.researchgate.net/publication/331642211_A_CASE_STUDY_TO_OPTIMIZE_FREEZE_DRYING_CONDITIONS_OF_CYCLODEXTRIN-BASED_FORMULATIONS [accessed Jul 26 2023].